Shifting Gears: Can Disease Course Be Changed in Patients with Pediatric Atopic Dermatitis? - European Medical Journal

Shifting Gears: Can Disease Course Be Changed in Patients with Pediatric Atopic Dermatitis?

Dermatology

This program is nonpromotional and is sponsored by Sanofi and Regeneron Pharmaceuticals.


 

Join experts Amy Paller and Peter Lio as they investigate atopic dermatitis as a risk factor for the development of food allergies, the benefits of early intervention in pediatric atopic dermatitis, and the potential for disease modification.

Learning Objectives:

  • Discover how atopic dermatitis can be a risk factor for the development of food allergies.
  • Describe potential opportunities for early intervention on disease trajectories.
  • Understand the potential for disease modification in atopic dermatitis.

Faculty

Amy Paller1

 

Peter Lio2

 

1. Northwestern Feinberg School of Medicine, Chicago, Illinois, USA
2. Medical Dermatology Associates of Chicago,  Illinois, USA

 

References

1. Sanofi and Regeneron Pharmaceuticals, Inc. 2025. Available at: https://www.adventprogram.com/us. Last accessed: April 7, 2025.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.